2019 AHA/ACC/HRS指南:房颤患者的管理(更新版)

2019-01-28 美国心脏协会 Circulation. 2019;139.

2019年1月,美国心脏协会(AHA),美国心脏病学会(ACC)以及心律协会(HRS)更新发布了房颤患者的管理指南。该指南是对2014版指南的更新,本次指南更新的主要内容是卒中预防(抗凝治疗),非维生素K类口服抗凝药(NOACs)被推荐作为华法林的首选替代药物。其他更新内容包括:节律控制、房颤导管消融、房颤合并急性冠脉综合征的管理、房颤检测的新装置以及减重等。

中文标题:

2019 AHA/ACC/HRS指南:房颤患者的管理(更新版)

英文标题:

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

发布机构:

美国心脏协会

发布日期:

2019-01-28

简要介绍:

2019年1月,美国心脏协会(AHA),美国心脏病学会(ACC)以及心律协会(HRS)更新发布了房颤患者的管理指南。该指南是对2014版指南的更新,本次指南更新的主要内容是卒中预防(抗凝治疗),非维生素K类口服抗凝药(NOACs)被推荐作为华法林的首选替代药物。其他更新内容包括:节律控制、房颤导管消融、房颤合并急性冠脉综合征的管理、房颤检测的新装置以及减重等。 

拓展指南:房颤相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 AHA/ACC/HRS指南:房颤患者的管理(更新版))] GetToolGuiderByIdResponse(projectId=1, id=bf6ac1c00169e6be, title=2019 AHA/ACC/HRS指南:房颤患者的管理(更新版), enTitle=2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation, guiderFrom=Circulation. 2019;139., authorId=null, author=, summary=2019年1月,美国心脏协会(AHA),美国心脏病学会(ACC)以及心律协会(HRS)更新发布了房颤患者的管理指南。该指南是对2014版指南的更新,本次指南更新的主要内容是卒中预防(抗凝治疗),非维生素K类口服抗凝药(NOACs)被推荐作为华法林的首选替代药物。其他更新内容包括:节律控制、房颤导管消融、房颤合并急性冠脉综合征的管理、房颤检测的新装置以及减重等。 , cover=, journalId=null, articlesId=null, associationId=60, associationName=美国心脏协会, associationIntro=美国心脏协会(AHA,American Heart Association)是心脏病学领域比较正要的学会之一,致力于心脏病和卒中的预防与治疗,提供相关继续教育、流行病学年度报告。每年举办学术年会报道中的的临床试验结果等,有官方杂志《美国心脏协会杂志》,提供心血管疾病和卒中相关的指南及专家共识,更新的比较快。, copyright=0, guiderPublishedTime=Mon Jan 28 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>2019年1月,美国心脏协会(AHA),美国心脏病学会(ACC)以及心律协会(HRS)更新发布了房颤患者的管理指南。该指南是对2014版指南的更新,本次指南更新的主要内容是卒中预防(抗凝治疗),非维生素K类口服抗凝药(NOACs)被推荐作为华法林的首选替代药物。其他更新内容包括:节律控制、房颤导管消融、房颤合并急性冠脉综合征的管理、房颤检测的新装置以及减重等。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>房颤</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=928cf1c001632ebd" title="2018 CHEST指南:房颤抗栓治疗" target=_blank>2018 CHEST指南:房颤抗栓治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=98f841c00162a09b" title="2018 NHFA/CSANZ临床指南:心房颤动的诊断和管理" target=_blank>2018 NHFA/CSANZ临床指南:心房颤动的诊断和管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=c35121c00162226a" title="2018 欧洲联合共识声明:房颤患者表现为急性冠脉综合征和/或经皮心血管介入治疗的抗栓治疗管理" target=_blank>2018 欧洲联合共识声明:房颤患者表现为急性冠脉综合征和/或经皮心血管介入治疗的抗栓治疗管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=445b61c0015e2325" title="2018 EHRA实践指导:房颤患者应用非维生素K拮抗剂口服抗凝药" target=_blank>2018 EHRA实践指导:房颤患者应用非维生素K拮抗剂口服抗凝药</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=239281c00151e6c5" title="2017 EHRA/ESC共识文件:心脏瓣膜病相关性房颤的抗栓治疗" target=_blank>2017 EHRA/ESC共识文件:心脏瓣膜病相关性房颤的抗栓治疗</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E6%88%BF%E9%A2%A4" target=_blank>有关房颤更多指南</a></ul>, tagList=[TagDto(tagId=367, tagName=心房颤动)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=14661, appHits=1514, showAppHits=11, pcHits=9094, showPcHits=6257, likes=266, shares=45, comments=7, approvalStatus=1, publishedTime=Fri Feb 08 21:56:04 CST 2019, publishedTimeString=2019-01-28, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Feb 08 21:56:04 CST 2019, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 13:51:34 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 AHA/ACC/HRS指南:房颤患者的管理(更新版))])
2019 AHA/ACC/HRS指南:房颤患者的管理(更新版)
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=925690, encodeId=93869256907b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa782569271, createdName=1257d324m68暂无昵称, createdTime=Sat Feb 20 07:50:15 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901550, encodeId=7c7590155029, content=怎么下载?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/916441d2913648269ede0b8db11ab6c2/0a36cd040f95424b9d105ae671387d9a.jpg, createdBy=52415437799, createdName=百度人生, createdTime=Mon Nov 23 20:14:46 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893598, encodeId=683589359846, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201021/ca8787cdc6654f4aaf585d0d0d512b58/44909b2362294ce28f84385675732298.jpg, createdBy=aecb2334654, createdName=1227991dm00暂无昵称, createdTime=Wed Oct 21 22:03:28 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891183, encodeId=ce45891183ab, content=非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75c55424163, createdName=ms9000001186008086, createdTime=Sun Oct 11 01:03:43 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887226, encodeId=708788e2266a, content=非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67332350276, createdName=122acd67m47暂无昵称, createdTime=Mon Sep 21 22:40:31 CST 2020, time=2020-09-21, status=1, ipAttribution=)]
    2021-02-20 1257d324m68暂无昵称

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=925690, encodeId=93869256907b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa782569271, createdName=1257d324m68暂无昵称, createdTime=Sat Feb 20 07:50:15 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901550, encodeId=7c7590155029, content=怎么下载?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/916441d2913648269ede0b8db11ab6c2/0a36cd040f95424b9d105ae671387d9a.jpg, createdBy=52415437799, createdName=百度人生, createdTime=Mon Nov 23 20:14:46 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893598, encodeId=683589359846, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201021/ca8787cdc6654f4aaf585d0d0d512b58/44909b2362294ce28f84385675732298.jpg, createdBy=aecb2334654, createdName=1227991dm00暂无昵称, createdTime=Wed Oct 21 22:03:28 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891183, encodeId=ce45891183ab, content=非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75c55424163, createdName=ms9000001186008086, createdTime=Sun Oct 11 01:03:43 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887226, encodeId=708788e2266a, content=非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67332350276, createdName=122acd67m47暂无昵称, createdTime=Mon Sep 21 22:40:31 CST 2020, time=2020-09-21, status=1, ipAttribution=)]
    2020-11-23 百度人生

    怎么下载?

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=925690, encodeId=93869256907b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa782569271, createdName=1257d324m68暂无昵称, createdTime=Sat Feb 20 07:50:15 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901550, encodeId=7c7590155029, content=怎么下载?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/916441d2913648269ede0b8db11ab6c2/0a36cd040f95424b9d105ae671387d9a.jpg, createdBy=52415437799, createdName=百度人生, createdTime=Mon Nov 23 20:14:46 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893598, encodeId=683589359846, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201021/ca8787cdc6654f4aaf585d0d0d512b58/44909b2362294ce28f84385675732298.jpg, createdBy=aecb2334654, createdName=1227991dm00暂无昵称, createdTime=Wed Oct 21 22:03:28 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891183, encodeId=ce45891183ab, content=非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75c55424163, createdName=ms9000001186008086, createdTime=Sun Oct 11 01:03:43 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887226, encodeId=708788e2266a, content=非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67332350276, createdName=122acd67m47暂无昵称, createdTime=Mon Sep 21 22:40:31 CST 2020, time=2020-09-21, status=1, ipAttribution=)]
    2020-10-21 1227991dm00暂无昵称

    很有用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=925690, encodeId=93869256907b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa782569271, createdName=1257d324m68暂无昵称, createdTime=Sat Feb 20 07:50:15 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901550, encodeId=7c7590155029, content=怎么下载?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/916441d2913648269ede0b8db11ab6c2/0a36cd040f95424b9d105ae671387d9a.jpg, createdBy=52415437799, createdName=百度人生, createdTime=Mon Nov 23 20:14:46 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893598, encodeId=683589359846, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201021/ca8787cdc6654f4aaf585d0d0d512b58/44909b2362294ce28f84385675732298.jpg, createdBy=aecb2334654, createdName=1227991dm00暂无昵称, createdTime=Wed Oct 21 22:03:28 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891183, encodeId=ce45891183ab, content=非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75c55424163, createdName=ms9000001186008086, createdTime=Sun Oct 11 01:03:43 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887226, encodeId=708788e2266a, content=非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67332350276, createdName=122acd67m47暂无昵称, createdTime=Mon Sep 21 22:40:31 CST 2020, time=2020-09-21, status=1, ipAttribution=)]
    2020-10-11 ms9000001186008086

    非常棒

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=925690, encodeId=93869256907b, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aa782569271, createdName=1257d324m68暂无昵称, createdTime=Sat Feb 20 07:50:15 CST 2021, time=2021-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=901550, encodeId=7c7590155029, content=怎么下载?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201123/916441d2913648269ede0b8db11ab6c2/0a36cd040f95424b9d105ae671387d9a.jpg, createdBy=52415437799, createdName=百度人生, createdTime=Mon Nov 23 20:14:46 CST 2020, time=2020-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893598, encodeId=683589359846, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201021/ca8787cdc6654f4aaf585d0d0d512b58/44909b2362294ce28f84385675732298.jpg, createdBy=aecb2334654, createdName=1227991dm00暂无昵称, createdTime=Wed Oct 21 22:03:28 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=891183, encodeId=ce45891183ab, content=非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75c55424163, createdName=ms9000001186008086, createdTime=Sun Oct 11 01:03:43 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887226, encodeId=708788e2266a, content=非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67332350276, createdName=122acd67m47暂无昵称, createdTime=Mon Sep 21 22:40:31 CST 2020, time=2020-09-21, status=1, ipAttribution=)]
    2020-09-21 122acd67m47暂无昵称

    非常棒

    0